Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adagio Therapeutics, Inc. | Chief Development Officer | Stock Option (Right to Buy) | 175K | Jan 30, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IVVD | Adagio Therapeutics, Inc. | Jan 30, 2022 | 1 | $0 | 4 | Feb 1, 2022 | Chief Development Officer |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Chief Development Officer |